NADH

200-393-0

4J24DQ0916

58-68-4

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl [(2R,3S,4R,5R)-5-(3-carbamoyl-1(4H)-pyridinyl)-3,4-dihydroxytetrahydro-2-furanyl]methyl dihydrogen diphosphate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

DPNH

NADH

[Wiki]

nicotinamide adenine dinucleotide (reduced)

Reduced nicotinamide adenine dinucleotide

Reduced nicotinamide adenine diphosphate

1,4,5,6-Tetrahydronicotinamide adenine dinucleotide

1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE

1,4-dihydronicotinamide adenine dinucleotide; DPNH; NAD reduced form; Nicotinamide adenine dinucleotide (reduced); Nicotinamide-adenine dinucleotide, reduced; Reduced nicotinamide adenine diphosphate; Reduced nicotinamide-adenine dinucleotide

1,4-dihydronicotinamide adenine dinucleotide; DPNH; nicotinamide adenine dinucleotide (reduced)

79324

[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2R,3R,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid

[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-[[(2R,3R,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid[[(2R,3R,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy]phosphinic acid

[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy({[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy)phosphinic acid

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphin

Adenosine 5′-(trihydrogen diphosphate), P′->5′-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide (9CI)

Adenosine 5′-(trihydrogen pyrophosphate), 5′-5′-ester with 1,4-dihydro-1β-D-ribofuranosylnicotinamide

Adenosine 5′-(trihydrogen pyrophosphate), 5′->5′-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (8CI)

adenosine 5′-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate}

Adenosine pyrophosphate, 5′->5′-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (7CI)

b-DPNH

b-NADH

Dihydrocodehydrogenase I

Dihydrocozymase

dihydronicotinamide adenine dinucleotide

Dihydronicotinamide mononucleotide

dihydronicotinamide-adenine dinucleotide

ENADA

NAd

NAD reduced form

NAJ

NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM)

Reduced codehydrogenase I

Reduced diphosphopyridine nucleotide

Reduced nicotinamide-adenine dinucleotide

TXD

{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphinic acid

α-Nicotinamideadeninedinucleotide

β-DPNH

β-NADH